Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.47 |
| ▸ | CA1 | P00915 | 11/20 | 0.47 |
| ▸ | CA9 | Q16790 | 7/20 | 0.47 |
| ▸ | CA6 | P23280 | 3/20 | 0.47 |
| ▸ | CA5A | P35218 | 3/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | PTGES2 | Q9H7Z7 | 3/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | METAP2 | P50579 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7362559 | 0.98 | CA2 (0.45) | CA2CA1CA9CA6CA5A | |
| Ammonia Solution, Strong SCHEMBL28150872 | 0.98 | CA2 (0.45) | CA2CA1CA9CA6CA5A | |
| Hydrochloric Acid SCHEMBL12481385 | 0.98 | CA2 (0.45) | CA2CA1CA9CA6CA5A | |
| SCHEMBL30140890 | 0.89 | CA2 (0.49) | CA2CA1CA9CA6CA5A | |
| SCHEMBL51728 | 0.89 | CA2 (0.49) | CA2CA1CA9CA6CA5A | |
| SCHEMBL8349565 | 0.87 | CA2 (0.54) | CA2CA1CA9CA6CA5A | |
| SCHEMBL1881549 | 0.87 | CA2 (0.50) | CA2CA1CA9CA6CA5A | |
| Ammonia Solution, Strong SCHEMBL28168503 | 0.87 | CA2 (0.47) | CA2CA1CA9CA6CA5A | |
| Methane SCHEMBL27933205 | 0.87 | CA2 (0.47) | CA2CA1CA9CA6CA5A | |
| SCHEMBL7444688 | 0.87 | CA2 (0.47) | CA2CA1CA9CA6CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | GENECODE (EE) | 2026-01-22 | — | — | US | claimed |
| CN-113227036-A | Ethylenediamine compound and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2021-08-06 | — | — | CN | claimed |
| CN-108440856-A | Dye-colored body and method for producing same | 谦华科技股份有限公司 | 2018-08-24 | — | — | CN | claimed |
| EP-3329047-A1 | CHEMICAL COMPOSITION FOR ANTI-CORROSION MINERAL PAPER | Cheng Kit Yew, Nelson (SG) | 2018-06-06 | — | — | EP | claimed |
| CN-103588697-B | Disubstituted benzenes sulfamide compound of one class 2,5 and its production and use | 中国科学院上海药物研究所 | 2017-09-15 | — | — | CN | claimed |
| CN-106588742-A | Pyroglutamic acid-derived hydrogen-bonding organic catalyst and its preparation method and application | 中南大学 | 2017-04-26 | — | — | CN | claimed |
| JP-4851328-B2 | — | — | 2012-01-11 | — | — | JP | claimed |
| EP-1976498-A2 | CHEMICAL COMPOUNDS | SmithKline Beecham Corporation (US) | 2008-10-08 | — | — | EP | claimed |
| US-20080207588-A1 | Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines | CHU DANIEL T W | 2008-08-28 | — | — | US | claimed |
| WO-2007127505-A2 | USE OF SULFONAMIDE DERIVATIVES IN THE TREATMENT OF DISORDERS OF THE METABOLISM AND THE NERVOUS SYSTEM | SMITHKLINE BEECHAM CORPORATION (US) | 2007-11-08 | — | — | WO | claimed |
| JP-2007506692-A | — | — | 2007-03-22 | — | — | JP | claimed |
| EP-1670470-A1 | PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS | Actelion Pharmaceuticals Ltd. (CH) | 2006-06-21 | — | — | EP | claimed |
| WO-2006047774-A1 | MULTILAYERED PIPES COMPRISING HYDROLYSIS RESISTANT POLYAMIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-05-04 | — | — | WO | claimed |
| WO-2006047776-A2 | MARINE UMBILICAL COMPRISING HYDROLYSIS RESISTANT POLYAMIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-05-04 | — | — | WO | claimed |
| EP-1648896-A1 | 7-SUBSTITUTED 3-NITRO-PYRAZOLO [1,5-A] PYRIMIDINES | FERRER INTERNACIONAL, S.A. (ES) | 2006-04-26 | — | — | EP | claimed |
| WO-2005030209-A1 | PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2005-04-07 | — | — | WO | claimed |
| WO-2005014596-A1 | 7-SUBSTITUTED 3-NITRO-PYRAZOLO `1,5-A! PYRIMIDINES | FERRER INTERNACIONAL, S.A. (ES) | 2005-02-17 | — | — | WO | claimed |
| EP-1165866-B1 | ABRASIVE FILAMENTS OF PLASTICIZED POLYAMIDES | DU PONT (US) | 2004-01-28 | — | — | EP | claimed |
| EP-1283832-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | BIOVITRUM AB (SE) | 2003-02-19 | — | — | EP | claimed |
| WO-2001090092-A1 | INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 | BIOVITRUM AB (SE) | 2001-11-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207588-A1 | Spiro-Heterocyclic Chromans, Thiochromans and Dihydroquinolines | CBR3, CBR1, DHRS9 | CA2 3822/4885CA1 4074/4885CA9 672/4885 |
| US-20260022096-A1 | NOVEL SULFONAMIDES AND THEIR USE AS NEUROPROTECTIVE AND/OR NEURORESTORATIVE AGENTS | CNR1, CDR2, SMN1; SMN2 | CA2 240/4885CA1 93/4885CA9 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.